COVID-19 is a global pandemic triggered by the severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 entry point involves the interaction with …

The complex pathophysiologic interplay between SARS-CoV-2 infection and complement
activation is the subject of active investigation. It is clinically mirrored by the occurrence of …

Objectives To summarize the epidemiologic, clinical, and laboratory characteristics of
autoimmune hemolytic anemia (AIHA) secondary to severe acute respiratory syndrome …

Abstract The SARS‐coronavirus‐2 (SARS‐CoV‐2) that causes coronavirus disease 2019
(COVID‐19), has spread worldwide and caused a global health emergency. SARS‐CoV‐2 …

Abstract Coronavirus disease 2019 (COVID-19) has been associated with a spectrum of
reported hematological complications ranging from immune cytopenias to thromboembolic …

During the ongoing coronavirus disease 2019 (COVID-19) pandemic, a number of
autoimmune diseases have been found to be associated with severe acute respiratory …

SARS-CoV-2 is a novel virus that is known to have a predilection for complications
associated with the respiratory system. Although COVID-19 has a wide spectrum of …

Autoimmune hemolytic anemia (AIHA) is a condition characterized by the increased
destruction of red blood cells (RBCs) mediated by anti-erythrocyte autoantibodies with or …

The article analyses data on the occurrence of hematological abnormalities in severe acute
respiratory syndrome 2 infection. Among these hematological abnormalities, the majority of …

COVID-19 posed a major challenge to the healthcare system and resources worldwide. The
popularization of vaccines and the adoption of numerous prevention and control measures …